InsiderTrades

Form 4 for WGS GeneDx Holdings Corp.

Accepted 2025-06-03 00:00:00 ET · period of report 2025-06-01 · accession 0001415889-25-015430 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-06-03 2025-06-01 WGS Feeley Kevin CFO M - OptEx $0.00 +718 4,475 +19% $0
D 2025-06-03 2025-06-02 WGS Feeley Kevin CFO S - Sale+OE $71.26 -370 4,105 -8% -$26.4K
D 2025-06-03 2025-06-01 WGS Feeley Kevin CFO M - OptEx $0.00 -718 3,586 -17% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2025-06-01 M A 718 $0.00 4,475 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
2 Common Class A Common Stock 2025-06-02 S D 370 $71.26 4,105 D — —
3 Derivative Restricted Stock Unit 2025-06-01 M D 718 $0.00 3,586 D — · — to — 718 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F3) 6.25% vest in quarterly installments over the 4-year period commencing on December 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.